Deubiquitination of DNM1L by USP3 triggers the development and metastasis of gallbladder carcinoma
Our findings suggest that DNM1L is a promising clinical target for GBC treatment and that focusing on DNM1L may provide new insights into GBC strategy.
Authors
- Ruopeng Liang
- Zhenya Wang (ORCID: https://orcid.org/0000-0001-6880-1849)
- Chaojie Lin
- Shitao Wu (ORCID: https://orcid.org/0000-0002-5735-9132)
- Jing Liu (ORCID: https://orcid.org/0000-0002-3113-4015)
- Xiaoxue Zhang (ORCID: https://orcid.org/0000-0001-7704-646X)
- Rongtao Zhu (ORCID: https://orcid.org/0000-0003-3655-9458)
- Hao Chen (ORCID: https://orcid.org/0000-0002-7288-2124)
- Yunpeng Zhai (ORCID: https://orcid.org/0000-0002-3344-4543)
- Yu Zhang (ORCID: https://orcid.org/0009-0005-6052-7087)
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Biology Direct
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s13062-025-00637-8
- Citations
- 2
- Primary Topic
- Cancer, Lipids, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.87